Alpha-2 Antiplasmin Market Growth, Trends and Forecast up to 2019

Alpha-2 Antiplasmin or plasmin inhibitor, is a type of glycoprotein synthesized by the liver, kidneys and other tissues of the body. It is a serine protease inhibitor which belongs to the Serpin superfamily that acts as the primary inhibitor of the serine protease plasmin. Fibrinolysis occurs due to the conversion of plasminogen to serine protease plasmin by plasminogen activator. Deficiency of Alpha 2 antiplasmin causes a bleeding disorder owing to the increase fibrinolysis. Alpha-2 antiplasmin is the protein responsible for the degradation of fibrin clots and inhibition of fibrinolysis.

In the geographical perspective, North America is the leading market owing to the rise in cases of metabolic syndrome. It has been proved that excess levels of alpha-2 antiplasmin is associated with metabolic syndrome and other cardiovascular diseases. Deficiency of alpha-2 antiplasmin protein causes development of atherosclerotic plaque which results in various heart diseases.According to the American Heart Association almost 35% of adults in the U.S. are suffering from metabolic syndrome. Furthermore, the Europe and Asia-Pacific regions are expected to witness increased market traction due to increased incidence rate of cardiovascular diseases.

 

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1842

 

The major factors driving this market are advances in the coagulation testing practices, increasing use of automated instrumentation are rise in cases of cardiovascular diseases. Moreover, factors such as technological advancement in the hospital infrastructures and high adoption rate of preventive diagnostic tests are also expected to drive the market. However, high development costs, need of highly sophisticated instruments and stringent regulatory policies are some of the restraints that could impede the growth of the market globally.

Some of the notable players in this industry segment includes Abbott Laboratories, Axis-Shield plc., Bio/Data Corporation, Becton Dickinson, Corgenix Medical Corporation, Helena Laboratories, Instrumentation Laboratory, Roche, Sysmex Corporation and Thermo Fisher Scientific, amongst others.

 

Enquiry for discount on this report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1842

 

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

 

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Showing 1 reaction

Please check your e-mail for a link to activate your account.
  • published this page in Submit Content 2018-02-14 02:35:35 -0800

connect